Serina Therapeutics, Inc. Quarterly Interest Expense in USD from Q3 2021 to Q1 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of the cost of borrowed funds accounted for as interest expense.
Summary
Serina Therapeutics, Inc. quarterly/annual Interest Expense history and growth rate from Q3 2021 to Q1 2024.
  • Serina Therapeutics, Inc. Interest Expense for the quarter ending March 31, 2024 was $99K, a 15.1% increase year-over-year.
  • Serina Therapeutics, Inc. Interest Expense for the twelve months ending March 31, 2024 was $4.91M, a 72.4% increase year-over-year.
  • Serina Therapeutics, Inc. annual Interest Expense for 2023 was $4.9M, a 46.9% increase from 2022.
  • Serina Therapeutics, Inc. annual Interest Expense for 2022 was $3.34M, a 204% increase from 2021.
Interest Expense, Trailing 12 Months (USD)
Interest Expense, Quarterly (USD)
Interest Expense, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2024 $4.91M $99K +$13K +15.1% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-14
Q4 2023 $4.9M $986K +$8K +0.82% Oct 1, 2023 Dec 31, 2023 10-K 2024-03-22
Q3 2023 $4.89M $3.04M +$2.11M +229% Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-14
Q2 2023 $2.78M $792K -$71K -8.23% Apr 1, 2023 Jun 30, 2023 10-Q 2023-08-14
Q1 2023 $2.85M $86K -$485K -84.9% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-14
Q4 2022 $3.34M $978K Oct 1, 2022 Dec 31, 2022 10-K 2024-03-22
Q3 2022 $923K +$638K +224% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-14
Q2 2022 $863K Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-14
Q1 2022 $571K Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-12
Q3 2021 $285K Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-10
* An asterisk sign (*) next to the value indicates that the value is likely invalid.